Stay updated on Autologous LN-145 in NSCLC Clinical Trial
Sign up to get notified when there's something new on the Autologous LN-145 in NSCLC Clinical Trial page.

Latest updates to the Autologous LN-145 in NSCLC Clinical Trial page
- CheckyesterdayNo Change Detected
- Check8 days agoChange DetectedNew help and navigation items have been added to the study record page, including Check who can join, Find Contact Information, How to Read a Study Record, Common Questions, and How to Join a Study. Additionally, the label for the treatment section has been updated from 'Intervention / Treatment' to 'Intervention/Treatment' and the revision tag now reads v3.6.0.SummaryDifference0.2%

- Check15 days agoChange DetectedThe page's revision label was updated to Revision: v3.5.5, replacing the previous v3.5.4, indicating a new software release for the site.SummaryDifference0.0%

- Check36 days agoChange DetectedRevision updated from v3.5.3 to v3.5.4, indicating a new revision of the page’s metadata. This is a minor update to the page version and does not change the visible content.SummaryDifference0.0%

- Check58 days agoChange DetectedA minor page revision/build identifier was updated from `v3.5.2` to `v3.5.3`, indicating a technical site update without altering the study information shown.SummaryDifference0.0%

- Check65 days agoChange DetectedNew study sites were added: Hospital Universitario de Salamanca (Salamanca, Spain); Fondazione IRCCS Policlinico San Matteo di Pavia (Pavia, Italy); Charite- Universitätsklinikum Berlin (Berlin, Germany); Gustave Roussy Cancer Campus (Villejuif, France); CHRU de Poitiers La Miletrie (Poitiers, France); CHU Nice (Nice, France); Banner Health MD Anderson (Gilbert, AZ). The total number of study locations is now 91.SummaryDifference0.8%

- Check94 days agoChange DetectedRevision: v3.5.0 was added and Revision: v3.4.3 was removed.SummaryDifference0.0%

Stay in the know with updates to Autologous LN-145 in NSCLC Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Autologous LN-145 in NSCLC Clinical Trial page.